Pharma-Bio Serv Statistics
Total Valuation
Pharma-Bio Serv has a market cap or net worth of 13.59 million. The enterprise value is 2.76 million.
| Market Cap | 13.59M |
| Enterprise Value | 2.76M |
Important Dates
The last earnings date was Thursday, January 29, 2026.
| Earnings Date | Jan 29, 2026 |
| Ex-Dividend Date | Feb 28, 2025 |
Share Statistics
Pharma-Bio Serv has 22.90 million shares outstanding. The number of shares has decreased by -0.08% in one year.
| Current Share Class | 22.90M |
| Shares Outstanding | 22.90M |
| Shares Change (YoY) | -0.08% |
| Shares Change (QoQ) | +0.03% |
| Owned by Insiders (%) | 54.98% |
| Owned by Institutions (%) | 1.49% |
| Float | 8.37M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | 5.39 |
| PS Ratio | 1.51 |
| PB Ratio | 1.14 |
| P/TBV Ratio | 1.14 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -27.48 |
| EV / Sales | 0.31 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | -12.46 |
Financial Position
The company has a current ratio of 7.70, with a Debt / Equity ratio of 0.00.
| Current Ratio | 7.70 |
| Quick Ratio | 7.60 |
| Debt / Equity | 0.00 |
| Debt / EBITDA | n/a |
| Debt / FCF | -0.13 |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -0.78% and return on invested capital (ROIC) is -54.01%.
| Return on Equity (ROE) | -0.78% |
| Return on Assets (ROA) | -2.66% |
| Return on Invested Capital (ROIC) | -54.01% |
| Return on Capital Employed (ROCE) | -5.35% |
| Weighted Average Cost of Capital (WACC) | 8.08% |
| Revenue Per Employee | 163,656 |
| Profits Per Employee | -1,827 |
| Employee Count | 55 |
| Asset Turnover | 0.60 |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, Pharma-Bio Serv has paid 6,203 in taxes.
| Income Tax | 6,203 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +2.08% in the last 52 weeks. The beta is 0.70, so Pharma-Bio Serv's price volatility has been lower than the market average.
| Beta (5Y) | 0.70 |
| 52-Week Price Change | +2.08% |
| 50-Day Moving Average | 0.57 |
| 200-Day Moving Average | 0.55 |
| Relative Strength Index (RSI) | 54.97 |
| Average Volume (20 Days) | 8,908 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | 0.06 |
Income Statement
In the last 12 months, Pharma-Bio Serv had revenue of 9.00 million and -100,463 in losses. Loss per share was -0.00.
| Revenue | 9.00M |
| Gross Profit | 2.91M |
| Operating Income | -637,662 |
| Pretax Income | -94,260 |
| Net Income | -100,463 |
| EBITDA | -577,796 |
| EBIT | -637,662 |
| Loss Per Share | -0.00 |
Balance Sheet
The company has 10.85 million in cash and 28,834 in debt, with a net cash position of 10.83 million or 0.47 per share.
| Cash & Cash Equivalents | 10.85M |
| Total Debt | 28,834 |
| Net Cash | 10.83M |
| Net Cash Per Share | 0.47 |
| Equity (Book Value) | 11.91M |
| Book Value Per Share | 0.52 |
| Working Capital | 11.65M |
Cash Flow
In the last 12 months, operating cash flow was -214,886 and capital expenditures -6,644, giving a free cash flow of -221,530.
| Operating Cash Flow | -214,886 |
| Capital Expenditures | -6,644 |
| Free Cash Flow | -221,530 |
| FCF Per Share | -0.01 |
Margins
Gross margin is 32.33%, with operating and profit margins of -7.08% and -1.12%.
| Gross Margin | 32.33% |
| Operating Margin | -7.08% |
| Pretax Margin | -1.05% |
| Profit Margin | -1.12% |
| EBITDA Margin | -6.42% |
| EBIT Margin | -7.08% |
| FCF Margin | n/a |
Dividends & Yields
This stock pays an annual dividend of 0.08, which amounts to a dividend yield of 12.64%.
| Dividend Per Share | 0.08 |
| Dividend Yield | 12.64% |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | 0.08% |
| Shareholder Yield | 12.72% |
| Earnings Yield | -0.74% |
| FCF Yield | -1.63% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Pharma-Bio Serv has an Altman Z-Score of 6.96 and a Piotroski F-Score of 2.
| Altman Z-Score | 6.96 |
| Piotroski F-Score | 2 |